Study of Nucleus 24 Auditory Brainstem Implant (ABI) in Adult Non-Neurofibromatosis Type 2 Subjects
The goal of this MEEI Auditory Brainstem Implant (ABI) research study is to find new ways to
improve hearing in patients who are deaf and cannot receive a cochlear implant. The ABI is
a surgically placed bionic implant that converts sounds into electrical signals that are
directly transmitted to the cochlear nucleus, the first auditory center of the brain. For
many years, ABIs have improved the hearing of patients who are deaf due to brain tumors
associated with a genetic syndrome called Neurofibromatosis Type 2 (NF2). However, a number
of recent studies suggest that deaf patients who do not have NF2 and are not eligible for a
cochlear implant may also benefit from placement of an ABI. These preliminary studies
suggest that these non-NF2 or "nontumor" patients may actually have better outcomes after
ABI surgery than patients suffering from NF2. Patients who do not have NF2 and are deaf due
to damage to the hearing nerves or inner ears from infection, disease or injury are not
cochlear implant candidates and there are no other options to improve hearing in these cases
except for the ABI. Thus, the purpose of our study is to carefully analyze whether ABI
surgery improves the hearing and quality of life of non-NF2 patients based on subjective and
objective measures of their hearing before and after ABI surgery. In particular, we plan to
study ABI outcomes in non-NF2 patients, characterize the parameters used on their devices,
and determine the safety profile of ABIs in these patients.
Interventional
Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Peri-operative and post-operative complications
We will track any major and minor complications intra-operatively and post-operatively in all study participants.
5 years from date of surgery
Yes
Daniel J Lee, MD, FACS
Principal Investigator
MEEI, HMS, MGH
United States: Food and Drug Administration
MEEI HSC 12-061
NCT01736267
November 2012
November 2022
Name | Location |
---|---|
Massachusetts Eye and Ear Infirmary | Boston, Massachusetts 02114-3096 |